Re: Serum androgens as prognostic biomarkers in castration-resistant prostate cancer: results from an analysis of a randomized phase III trial.
Samir S
SS
Taneja
D000728:Androgens / Q000097:blood*; D000730:Androstadienes / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D011241:Prednisone / Q000008:administration & dosage*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000401:mortality*
D000728:Androgens; D000730:Androstadienes; D011241:Prednisone